TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Asymptomatic Volunteers Who Are Infected With Either Mycobacterium Tuberculosis (M.tb.), Human Immunodeficiency Virus (HIV) or Both
Brief Summary: This study is designed to evaluate the safety of MVA85A in asymptomatic volunteers in South Africa who are infected with M.tb, HIV or both. A single vaccination with MVA85A, when administered at a dose of 5 x 107pfu intradermally, is safe and highly immunogenic in mycobacterially naïve individuals, BCG vaccinated individuals and M.tb latently infected individuals. We will use the same vaccination regime in this study. Participants will be defined as being infected with M.tb.if they have a positive Elispot response to ESAT6 or CFP10. Participants will be defined as being infected with HIV.if they have a positive HIV rapid test (Determine®, Abbott Laboratories) followed by a positive HIV ELISA result. Participants will be identified from the general population living in Worcester, Western Cape, South Africa


Options:
A: Intervention Type: BIOLOGICAL; Name: BCG (SSI Strain); Assigned to Arm(s): N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: MVA 85A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: MVA 85A | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Biological: MVA 85A | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Biological: MVA 85A | Intervention Type: BIOLOGICAL; Name: MVA 85A; Assigned to Arm(s): 1, 2, 3, 4
C: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Biological: BCG: 100 microlitres ~ 2-8 x 105 pfu | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Biological: MVA85A: 1 x 108 pfu BCG: 100 microlitres ~ 2-8 x 105 pfu | Arm Label: Group C; Type: EXPERIMENTAL; Interventions: Biological: BCG: 100 microlitres ~ 2-8 x 105 pfu | Arm Label: Group D; Type: EXPERIMENTAL; Interventions: Biological: MVA85A: 1 x 108 pfu BCG: 100 microlitres ~ 2-8 x 105 pfu | Intervention Type: BIOLOGICAL; Name: BCG: 100 microlitres ~ 2-8 x 105 pfu; Assigned to Arm(s): Group A, Group C | Intervention Type: BIOLOGICAL; Name: MVA85A: 1 x 108 pfu BCG: 100 microlitres ~ 2-8 x 105 pfu; Assigned to Arm(s): Group B, Group D
D: Arm Label: MVA85A; Type: EXPERIMENTAL; Interventions: Biological: MVA85A, Biological: BCG Vaccine SSI | Arm Label: Candin; Type: ACTIVE_COMPARATOR; Interventions: Biological: Candin, Biological: BCG Vaccine SSI | Intervention Type: BIOLOGICAL; Name: MVA85A; Assigned to Arm(s): MVA85A | Intervention Type: BIOLOGICAL; Name: Candin; Assigned to Arm(s): Candin | Intervention Type: BIOLOGICAL; Name: BCG Vaccine SSI; Assigned to Arm(s): Candin, MVA85A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Study of the Immunogenicity of M. Bovis BCG (SSI Strain), Delivered Intradermally in Healthy Volunteers
Brief Summary: To assess the immunogenicity of M. bovis BCG (SSI strain), given intrademally in the standard dose used in clinical practice and to measure the development of the immune response in the first six months after administration. M. bovis BCG is a fully licensed vaccine that has been in routine clinical use for the last 50 years. It is the most widely administered vaccine in the world today and has an excellent safety record.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: BCG | Intervention Type: BIOLOGICAL; Name: BCG; Assigned to Arm(s): 1
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: MVA85A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Biological: MVA85A | Intervention Type: BIOLOGICAL; Name: MVA85A; Assigned to Arm(s): 1, 2
C: Arm Label: Investigational Vaccine; Type: EXPERIMENTAL; Interventions: Biological: MVA85A/AERAS-485 | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Candida Skin Test Antigen | Intervention Type: BIOLOGICAL; Name: MVA85A/AERAS-485; Assigned to Arm(s): Investigational Vaccine | Intervention Type: BIOLOGICAL; Name: Candida Skin Test Antigen; Assigned to Arm(s): Control Group
D: Intervention Type: BIOLOGICAL; Name: BCG (SSI Strain); Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Open-label, Randomized, and Multicentric Phase III Clinical Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV-1-infected Patients With CD4-positive T-lymphocytes Counts Above 200 permm3 ANRS HB 03 VIHVAC-B
Brief Summary: In HIV infected patients, individuals exposed to the virus of Hepatitis B are more susceptible to develop a chronic and severe liver disease with a major risk of cirrhosis and liver cancer.

However, the existing protocol of vaccination against Hepatitis B is less efficient in HIV-infected patients than in non HIV-infected-patients, and, in case of response, its longevity has to be followed up carefully. This study compares the efficacy of the standard protocol vaccination with GenHevac-B and 2 other protocols, a double-dose of GenHevac-B and a set of intradermal injections of Genhevac-B, in HIV-infected patients with lymphocytes T CD4 level above 200 permm3.


Options:
A: Intervention Type: BIOLOGICAL; Name: Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed; Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Measles-Mumps-Rubella Vaccine (Live); Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Pneumococcal Vaccine, Polyvalent (23-valent); Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Pneumococcal Conjugate Vaccine, Heptavalent; Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Hepatitis B Vaccine (Recombinant); Assigned to Arm(s): N/A
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Biological: GenHevac B Pasteur | Arm Label: B; Type: EXPERIMENTAL; Interventions: Biological: GenHevac B Pasteur | Arm Label: C; Type: EXPERIMENTAL; Interventions: Biological: GenHevac B Pasteur | Intervention Type: BIOLOGICAL; Name: GenHevac B Pasteur; Assigned to Arm(s): A | Intervention Type: BIOLOGICAL; Name: GenHevac B Pasteur; Assigned to Arm(s): B | Intervention Type: BIOLOGICAL; Name: GenHevac B Pasteur; Assigned to Arm(s): C
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: Engerix-B 20 mcg | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: Engerix-B 40 mcg | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Biological: Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg | Intervention Type: BIOLOGICAL; Name: Engerix-B 20 mcg; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Engerix-B 40 mcg; Assigned to Arm(s): 2 | Intervention Type: BIOLOGICAL; Name: Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg; Assigned to Arm(s): 3
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: Recombivax | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Biological: Twinrix | Intervention Type: BIOLOGICAL; Name: Recombivax; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Twinrix; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients
Brief Summary: The purpose of this study is to determine the effects of the anticholinesterase drug donepezil on sleep in Alzheimer disease patients. Sleep structure and respiratory parameters will be analyzed by polysomnography.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: donepezil | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: donepezil; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): B
B: Arm Label: Bright light therapy; Type: EXPERIMENTAL; Interventions: Device: Bright light therapy | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Bright light therapy; Assigned to Arm(s): Bright light therapy
C: Arm Label: Melatonin; Type: PLACEBO_COMPARATOR; Interventions: Drug: Melatonin 5 mg | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Melatonin 5 mg; Assigned to Arm(s): Melatonin | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): placebo
D: Arm Label: AZD5213 doseA; Type: EXPERIMENTAL; Interventions: Drug: AZD5213 | Arm Label: AZD5213 doseB; Type: EXPERIMENTAL; Interventions: Drug: AZD5213 | Arm Label: AZD5213 doseC; Type: EXPERIMENTAL; Interventions: Drug: AZD5213 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: AZD5213; Assigned to Arm(s): AZD5213 doseA | Intervention Type: DRUG; Name: AZD5213; Assigned to Arm(s): AZD5213 doseB | Intervention Type: DRUG; Name: AZD5213; Assigned to Arm(s): AZD5213 doseC | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients
Brief Summary: The purpose of this study is to determine the effects of the anticholinesterase drug donepezil on sleep in Alzheimer disease patients. Sleep structure and respiratory parameters will be analyzed by polysomnography.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: armodafinil | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: armodafinil; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: donepezil | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: donepezil; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): B
C: Arm Label: Budesonide; Type: EXPERIMENTAL; Interventions: Drug: Budesonide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Budesonide; Assigned to Arm(s): Budesonide | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
D: Arm Label: Donepezil; Type: EXPERIMENTAL; Interventions: Drug: donepezil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: donepezil; Assigned to Arm(s): Donepezil | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients
Brief Summary: The purpose of this study is to determine the effects of the anticholinesterase drug donepezil on sleep in Alzheimer disease patients. Sleep structure and respiratory parameters will be analyzed by polysomnography.


Options:
A: Intervention Type: DRUG; Name: SB-742457; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: donepezil; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Donepezil; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aricept (donepezil SR 23 mg) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Aricept (donepezil IR 10 mg) | Intervention Type: DRUG; Name: Aricept (donepezil SR 23 mg); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Aricept (donepezil IR 10 mg); Assigned to Arm(s): 2
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: donepezil | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: donepezil; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): B

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial Comparing the Effects of a Low Glycemic Load Diet With a Low Fat Diet on Hepatic Steatosis in Overweight Children and Adolescents
Brief Summary: There has been a recent increase in incidence of obesity and its associated morbidities, including T2 DM, hypertension and hepatic steatosis. Hepatic steatosis is a precursor to non-alcoholic steatohepatitis, cirrhosis and end-stage liver disease. The 1st reported case of pediatric hepatic steatosis was in 1980 and it is now affects 30-77% of overweight children. In addition to its association with obesity, hepatic steatosis has been associated with the metabolic syndrome, insulin resistance, and post-prandial hyperglycemia. Current treatment of hepatic steatosis includes weight loss with a hypocaloric low fat diet. Given the association with insulin resistance and post-prandial hyperglycemia, adult patients with hepatic steatosis that does not respond to weight loss are placed on insulin sensitizing drugs. We hypothesize that weight loss with a diet designed to decrease insulin resistance and post-prandial hyperglycemia, a low glycemic load diet, will provide a safe and effective way to decrease hepatic fat content in the pediatric population. This hypothesis will be tested with a randomized control trial comparing the effect of a low fat diet with a low glycemic load diet.


Options:
A: Arm Label: Diet: Dietary Advice; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: General Advice | Arm Label: Low glycemic index Mediterranean Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Low Glycemic Index Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: Low Glycemic Index Mediterranean Diet; Assigned to Arm(s): Low glycemic index Mediterranean Diet | Intervention Type: BEHAVIORAL; Name: General Advice; Assigned to Arm(s): Diet: Dietary Advice
B: Arm Label: Carbohydrate-restricted diet; Type: EXPERIMENTAL; Interventions: Other: Carbohydrate-restricted diet | Arm Label: Control, low-fat diet; Type: ACTIVE_COMPARATOR; Interventions: Other: Control, low-fat diet | Intervention Type: OTHER; Name: Carbohydrate-restricted diet; Assigned to Arm(s): Carbohydrate-restricted diet | Intervention Type: OTHER; Name: Control, low-fat diet; Assigned to Arm(s): Control, low-fat diet
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Low glycemic load diet | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Low fat diet | Intervention Type: BEHAVIORAL; Name: Low glycemic load diet; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Low fat diet; Assigned to Arm(s): 2
D: Arm Label: Control; Type: EXPERIMENTAL; Interventions: Behavioral: Unsupervised exercise training | Arm Label: lifestyle counseling and exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Supervised exercise training | Intervention Type: BEHAVIORAL; Name: Unsupervised exercise training; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Supervised exercise training; Assigned to Arm(s): lifestyle counseling and exercise

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dialectical Cognitive Traumatherapy (DCT) on Patients With Severe Posttraumatic Stress Disorder Following Sexual Abuse - A Randomised Controlled Trial
Brief Summary: The purpose of this study is to determine whether Dialectical Cognitive Traumatherapy is effective in the treatment of severe and chronic Posttraumatic Stress Disorder (PTSD) following childhood sexual abuse.


Options:
A: Arm Label: Escitalopram; Type: ACTIVE_COMPARATOR; Interventions: Drug: Escitalopram | Arm Label: Duloxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Duloxetine | Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive behavioral therapy (CBT) | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): Escitalopram | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy (CBT); Assigned to Arm(s): CBT
B: Arm Label: brief intervention to prevent suicide attempt; Type: EXPERIMENTAL; Interventions: Behavioral: Brief intervention to prevent suicide attempt | Arm Label: standard of care; Type: OTHER; Interventions: Behavioral: Enhanced treatment as usual | Intervention Type: BEHAVIORAL; Name: Brief intervention to prevent suicide attempt; Assigned to Arm(s): brief intervention to prevent suicide attempt | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual; Assigned to Arm(s): standard of care
C: Arm Label: 1; Type: NO_INTERVENTION; Interventions: Behavioral: Dialectical Cognitive Therapy | Intervention Type: BEHAVIORAL; Name: Dialectical Cognitive Therapy; Assigned to Arm(s): 1
D: Intervention Type: DRUG; Name: Topiramate; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dialectical Cognitive Traumatherapy (DCT) on Patients With Severe Posttraumatic Stress Disorder Following Sexual Abuse - A Randomised Controlled Trial
Brief Summary: The purpose of this study is to determine whether Dialectical Cognitive Traumatherapy is effective in the treatment of severe and chronic Posttraumatic Stress Disorder (PTSD) following childhood sexual abuse.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: Behavioral: Dialectical Cognitive Therapy | Intervention Type: BEHAVIORAL; Name: Dialectical Cognitive Therapy; Assigned to Arm(s): 1
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavioral therapy for adolescents (DBT-A) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Dialectical behavioral therapy for adolescents (DBT-A); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioural Therapy, Other: Treatment as usual | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioural Therapy; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Treatment as usual; Assigned to Arm(s): 1, 2
D: Arm Label: S-DBT; Type: EXPERIMENTAL; Interventions: Behavioral: Standard dialectical behavior therapy (SDBT) | Arm Label: DBT-I; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Individual DBT with no DBT group sessions (DBT-I) | Arm Label: DBT-S; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group Skills DBT with no DBT individual sessions (DBT-S) | Intervention Type: BEHAVIORAL; Name: Standard dialectical behavior therapy (SDBT); Assigned to Arm(s): S-DBT | Intervention Type: BEHAVIORAL; Name: Individual DBT with no DBT group sessions (DBT-I); Assigned to Arm(s): DBT-I | Intervention Type: BEHAVIORAL; Name: Group Skills DBT with no DBT individual sessions (DBT-S); Assigned to Arm(s): DBT-S

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dialectical Cognitive Traumatherapy (DCT) on Patients With Severe Posttraumatic Stress Disorder Following Sexual Abuse - A Randomised Controlled Trial
Brief Summary: The purpose of this study is to determine whether Dialectical Cognitive Traumatherapy is effective in the treatment of severe and chronic Posttraumatic Stress Disorder (PTSD) following childhood sexual abuse.


Options:
A: Arm Label: TFP; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Transference-Focused Psychotherapy | Arm Label: ECP; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: treatment by experienced community psychotherapists | Intervention Type: BEHAVIORAL; Name: Transference-Focused Psychotherapy; Assigned to Arm(s): TFP | Intervention Type: BEHAVIORAL; Name: treatment by experienced community psychotherapists; Assigned to Arm(s): ECP
B: Arm Label: 1; Type: NO_INTERVENTION; Interventions: Behavioral: Dialectical Cognitive Therapy | Intervention Type: BEHAVIORAL; Name: Dialectical Cognitive Therapy; Assigned to Arm(s): 1
C: Arm Label: S-DBT; Type: EXPERIMENTAL; Interventions: Behavioral: Standard dialectical behavior therapy (SDBT) | Arm Label: DBT-I; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Individual DBT with no DBT group sessions (DBT-I) | Arm Label: DBT-S; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group Skills DBT with no DBT individual sessions (DBT-S) | Intervention Type: BEHAVIORAL; Name: Standard dialectical behavior therapy (SDBT); Assigned to Arm(s): S-DBT | Intervention Type: BEHAVIORAL; Name: Individual DBT with no DBT group sessions (DBT-I); Assigned to Arm(s): DBT-I | Intervention Type: BEHAVIORAL; Name: Group Skills DBT with no DBT individual sessions (DBT-S); Assigned to Arm(s): DBT-S
D: Intervention Type: BEHAVIORAL; Name: Cognitive Therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Supportive Therapy; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dialectical Cognitive Traumatherapy (DCT) on Patients With Severe Posttraumatic Stress Disorder Following Sexual Abuse - A Randomised Controlled Trial
Brief Summary: The purpose of this study is to determine whether Dialectical Cognitive Traumatherapy is effective in the treatment of severe and chronic Posttraumatic Stress Disorder (PTSD) following childhood sexual abuse.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: Behavioral: Dialectical Cognitive Therapy | Intervention Type: BEHAVIORAL; Name: Dialectical Cognitive Therapy; Assigned to Arm(s): 1
B: Arm Label: Selegiline; Type: EXPERIMENTAL; Interventions: Drug: Selegiline | Arm Label: Placebo (for Selegiline); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for Selegiline) | Intervention Type: DRUG; Name: Selegiline; Assigned to Arm(s): Selegiline | Intervention Type: DRUG; Name: Placebo (for Selegiline); Assigned to Arm(s): Placebo (for Selegiline)
C: Arm Label: dynamic deconstructive psychotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: Psychodynamic Therapy | Arm Label: optimized community care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Optimized Community Care | Intervention Type: BEHAVIORAL; Name: Psychodynamic Therapy; Assigned to Arm(s): dynamic deconstructive psychotherapy | Intervention Type: BEHAVIORAL; Name: Optimized Community Care; Assigned to Arm(s): optimized community care
D: Intervention Type: BEHAVIORAL; Name: Cognitive Therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Supportive Therapy; Assigned to Arm(s): N/A

Answer: A